Disease Epidemiology / Clinical Course / Cancer

((A-074)) (A-074) Interventions for Improving the Uptake of Preventive Medication Treatments for Breast Cancer: A Systematic Review

((B-001)) (B-001) Impact of gabapentinoids use on healthcare utilization and expenditure among female breast cancer survivors in the United States: A propensity-score matched cohort study

((B-002)) (B-002) Association of new-onset hypertension and its treatment with survival in cancer patients: A retrospective cohort study using electronic medical record data.

((B-003)) (B-003) DARWIN EU® - Prevalence of Frailty and Polypharmacy in Selected Cancers: results from Six European Countries in a Real-World Context

((B-004)) (B-004) Risk of Cancer in Patients with First-Time Seizure: A Population-Based Cohort Study

((B-005)) (B-005) Factors Affected the Short-term Mortality in Patients with Non-Small Cell Lung Cancer

((B-006)) (B-006) Prediction Models for Diagnosis and Prognosis of Leukemia: Systematic Review and Critical Appraisal

((B-007)) (B-007) Updated Trends in incidence, prevalence, and survival in patients with Head and Neck Squamous Cell Carcinoma in the United States

((B-008)) (B-008) Comparing approaches to real-world progression-free survival estimation among patients with advanced melanoma on first-line immunotherapy

((B-009)) (B-009) Validity of Hospital Cancer Registry and Electronic Health Record Cancer Diagnoses Among a Large Academic-Community Health System in the United States

((B-010)) (B-010) Incidence Trends and Characterisation of Lung Cancer: a Multinational European Cohort Study

((B-011)) (B-011) Association Between Non-adherence to Oral Anticancer Monotherapy in Clinical Trials (CTs) and Progression-Free Survival (PFS) in Patients (pts) with R/R Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

((B-012)) (B-012) Comorbidity Assessment using Integrated EHR and Claims in a National Oncology Database

((B-013)) (B-013) Treatment Patterns on Early-Stage Melanoma: Results from a Multi-site Chart Review

((B-014)) (B-014) Bayesian Analysis of Linear Tumor Growth Rate: Case Study in VHL Disease

((B-015)) (B-015) Harnessing Real-World Clinicogenomics for Non-Small Cell Lung Cancer Drug Development: An Initial Report

((B-016)) (B-016) Trends in the Incidence of Monoclonal Gammopathy of Undetermined Significance (MGUS) Before and During the COVID-19 Pandemic

((B-017)) (B-017) Real-World Data Survival Patterns in Glioblastoma Patients

((B-018)) (B-018) Estimating the incidence and prevalencehe incidence of second primary malignancy in men diagnosed with prostate cancer in the US during 2000-2022, as recorded in the US SEER 17 Registries

((B-019)) (B-019) Prevalence of Chronic Myeloid Leukemia in the European Union

((B-020)) (B-020) Incidence and Risk Factors of chemotherapy-induced Nephrotoxicity in Cancer Patients with Proper Hydration and Dose Adjustments: A Prospective Hospital-based Study

((B-021)) (B-021) The value of integrating multi-care settings real world data for understanding prostate cancer management

((B-022)) (B-022) Integrated Multi-Setting Real-World Data to Advance Bladder Cancer Evidence Generation

((B-023)) (B-023) A novel salivary-based companion diagnostic device for early detection and monitoring of HER-2+ breast cancer patients in resource-limited settings

((B-024)) (B-024) Predictors of Skin Melanoma among Adult population and Its Impact on Quality of Life in the U.S.